Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Humacyte, Inc. - Common Stock (NQ:HUMA)

1.700 +0.060 (+3.66%)
Streaming Delayed Price Updated: 1:27 PM EDT, Oct 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,791,758
Open 1.680
Bid (Size) 1.690 (350)
Ask (Size) 1.700 (152)
Prev. Close 1.640
Today's Range 1.620 - 1.710
52wk Range 1.150 - 6.770
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top stock movements in today's session.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis. 
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Via Benzinga

Performance

YTD
-67.2%
-67.2%
1 Month
+20.6%
+20.6%
3 Month
-33.9%
-33.9%
6 Month
+47.8%
+47.8%
1 Year
-69.1%
-69.1%

More News

Read More
Which stocks are moving on Tuesday?
Via Chartmill
An Overview of Humacyte's Earnings
Via Benzinga
Exploring Humacyte's Earnings Expectations
Via Benzinga
Tuesday's session: gap up and gap down stocks
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Russell 2000 Hits All-Time Highs: 8 Stocks Power Small-Cap Comeback
Via Benzinga
Topics ETFs Economy
Which stocks are experiencing notable movement on Monday?
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Let's have a look at the top gainers and losers in the middle of the day of today's session.
Via Chartmill
Monday's session: gap up and gap down stocks
Via Chartmill
Humacyte Inc (NASDAQ:HUMA) Q2 2025 Earnings: Revenue Misses Estimates, Shares Drop 9.9% in Pre-Market
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Humacyte Posts Q2 Revenue Miss
Via The Motley Fool
Topics Intellectual Property
GE Vernova Posts Better-Than-Expected Earnings, Joins Thermo Fisher Scientific, Lennox International, General Dynamics And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Earnings Scheduled For August 11, 2025
Via Benzinga
Gold Falls 1%; ProKidney Shares Spike Higher
Via Benzinga
Microchip Technology, Tesla, Humacyte And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Gapping stocks in Tuesday's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
There are notable gap-ups and gap-downs in today's session.
Via Chartmill
Small-Caps Explode Higher As Tariff Fears Ease: Humacyte, Forward Air, FormFactor Top Russell 2000
Via Benzinga
Topics ETFs Government World Trade
Earnings Scheduled For May 13, 2025
Via Benzinga
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish
Via Stocktwits
Topics Earnings

Frequently Asked Questions

Is Humacyte, Inc. - Common Stock publicly traded?
Yes, Humacyte, Inc. - Common Stock is publicly traded.
What exchange does Humacyte, Inc. - Common Stock trade on?
Humacyte, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Humacyte, Inc. - Common Stock?
The ticker symbol for Humacyte, Inc. - Common Stock is HUMA on the Nasdaq Stock Market
What is the current price of Humacyte, Inc. - Common Stock?
The current price of Humacyte, Inc. - Common Stock is 1.700
When was Humacyte, Inc. - Common Stock last traded?
The last trade of Humacyte, Inc. - Common Stock was at 10/08/25 01:27 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.